title: [The most important aspects of risk assessment].
authors: Chirurgische Klinik, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1–3, 68 167 Mannheim. torsten.wilhelm@umm.de
authors: Torsten J
authors: TJ
authors: Wilhelm
authors: Stefan
authors: S
authors: Post
mesh_terms: D000465:Algorithms; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000097:blood / Q000188:drug therapy; D000077144:Clopidogrel; D013505:Digestive System Surgical Procedures; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D006305:Health Status Indicators; D006470:Hemorrhage / Q000097:blood* / Q000139:chemically induced* / Q000401:mortality; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D059035:Perioperative Period; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D018570:Risk Assessment; D013923:Thromboembolism / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D014781:Viscera / Q000601:surgery*
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D006493:Heparin; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin